1
Ulrich Speck, Bruno Scheller: Medical device for dispensing medicaments. Bayer Pharma Aktiengesellschaft, Millen White Zelano & Branigan P C, September 4, 2012: US08257305 (18 worldwide citation)

For selective treatment of diseased tissue sections or organ parts, the surface of medical devices entering into contact with areas thereof under pressure is coated with lipophilic substantially water-insoluble medicaments binding to various tissue components with good adherence thereto, said medica ...


2
COWAN Kevin P, TROCKI Mark, TUCKER Barry L, RHINEHART Edward J, HOFFMAN Raymond C, BERRY David H, UBER Arthur E: Seringue volumétrique, Displacement syringe. Bayer Pharma Aktiengesellschaft, COWAN Kevin P, TROCKI Mark, TUCKER Barry L, RHINEHART Edward J, HOFFMAN Raymond C, BERRY David H, UBER Arthur E, PARKS Jonathan C, November 3, 2011: WO/2011/137437 (17 worldwide citation)

A displacement syringe having a housing with a distal tip and a proximal end; a moveable outer plunger within the housing having an elongated passageway; at least one moveable inner plunger within the passageway of the outer plunger; at least one first seal between the outer plunger and the housing; ...


3
Susan Zeun, Holger Zimmermann, Susanne Parke: Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido. Bayer Pharma Aktiengesellschaft, Millen White Zelano & Branigan PC, January 8, 2013: US08349820 (13 worldwide citation)

The invention relates to the use, optionally together with oral contraception, of estradiol valerate or 17β-estradiol in combination with 17α-cyanomethyl-17-β-hydroxyestra-4,9-dien-3-one (dienogest) in a multistage or single-stage combination preparation for oral therapy to maintain and/or increase ...


4
Dirk Heimbach, Susanne Röhrig, Dirk Schneider, Ulrich Rester, Eckhard Bender, Mark Meininghaus, Katja Zimmermann, Dmitry Zubov, Anja Buchmüller, Georges Von Degenfeld, Christoph Gerdes, Michael Gerisch, Mark Jean Gnoth, Yolanda Cancho Grande, Mario Jeske, Kersten Matthias Gericke: Heteroaryl-substituted piperidines. Bayer Pharma Aktiengesellschaft, February 21, 2012: US08119663 (13 worldwide citation)

The invention relates to novel heteroaryl-substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular diseases a ...


5
MLETZKO Stephan, SCHÜRMANN Rolf, GUDE Kerstin: Formes pharmaceutiques orales solides à très faible dose pour hrt, Very low-dosed solid oral dosage forms for hrt. Bayer Pharma Aktiengesellschaft, MLETZKO Stephan, SCHÜRMANN Rolf, GUDE Kerstin, Plougmann & Vingtoft, October 20, 2011: WO/2011/128336 (13 worldwide citation)

The present invention relates to a very low-dosed dosage form for hormone replacement therapy (HRT). More particularly, the present invention concerns a solid oral dosage form comprising about 0.5 mg estradiol and about 0.25 mg drospirenone, and at least one pharmaceutically acceptable excipient. De ...


6

7

8

9
FOLLMANN Markus, STASCH Johannes Peter, REDLICH Gorden, ACKERSTAFF Jens, GRIEBENOW Nils, KNORR Andreas, WUNDER Frank, LI Volkhart Min Jian, BÄRFACKER Lars, WEIGAND Stefan: AZAHÉTÉROCYCLES BICYCLIQUES ET LEUR UTILISATION, BICYCLIC AZA HETEROCYCLES, AND USE THEREOF, BICYCLISCHE AZA-HETEROCYCLEN UND IHRE VERWENDUNG. BAYER PHARMA AKTIENGESELLSCHAFT, FOLLMANN Markus, STASCH Johannes Peter, REDLICH Gorden, ACKERSTAFF Jens, GRIEBENOW Nils, KNORR Andreas, WUNDER Frank, LI Volkhart Min Jian, BÄRFACKER Lars, WEIGAND Stefan, March 8, 2012: WO/2012/028647 (9 worldwide citation)

Die vorliegende Anmeldung betrifft neue, bicyclische Aza-Heterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung allein oder in Kombinationen zur Behandlung und/oder Prophylaxe von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prophylaxe von Krankh ...


10
FÜRSTNER CHANTAL: Bis-arylverknüpfte aryltriazolone und ihre verwendung (DE), Bisaryl-bonded aryltriazolones and use thereof (EN). BAYER PHARMA AKTIENGESELLSCHAFT, September 1, 2011: WO/2011/104322 (8 worldwide citation)

The present application relates to novel bisaryl-bonded 5-aryl-1,2,4-triazolone derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of disorders, and to the use thereof for production of medicaments for treatment and/or preven ...